Sign in
  • Home
  • About us
  • Categories
    • Biotech
    • Diagnostics
    • Plantech
    • Pharma
    • Miscellaneous
  • Events
  • Resources
  • White Papers
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
THE DAILY SCIENTIST
THE DAILY SCIENTIST
THE DAILY SCIENTIST
Search
  • Home
  • About us
  • Categories
    • Biotech
    • Diagnostics
    • Plantech
    • Pharma
    • Miscellaneous
  • Events
  • Resources
  • White Papers
Subscribe
THE DAILY SCIENTIST
Search
  • Home
  • About us
  • Categories
    • Biotech
    • Diagnostics
    • Plantech
    • Pharma
    • Miscellaneous
  • Events
  • Resources
  • White Papers
SubscribeSubscribe
Home Authors Posts by SignalChem

SignalChem

58 POSTS 0 COMMENTS
https://thedailyscientist.org
SignalChem is a leading biotechnology company with unique protein engineering technology and innovative drug discovery platforms. They provide a wide range of biological reagents with high quality for research, development and further manufacturing.
Oral Peptides Take Aim at Inflammation
Biotech

Oral Peptides Take Aim at Inflammation

SignalChem -
November 10, 2026
0
A New Chapter in Melanoma Research: Personalized Vaccines and the Tools Behind Discovery
Biotech

A New Chapter in Melanoma Research: Personalized Vaccines and the Tools Behind Discovery

SignalChem -
November 2, 2026
0
Advancing Influenza Antibody and Vaccine Development with Sino Biological
Biotech

Advancing Influenza Antibody and Vaccine Development with Sino Biological

SignalChem -
October 20, 2026
0
Keeping Pace with Influenza: Recombinant Antigens for 2026–2027 Vaccine Research
Biotech

Keeping Pace with Influenza: Recombinant Antigens for 2026–2027 Vaccine Research

SignalChem -
October 12, 2026
0
The Best of AIPAT 2026: Speakers, Award Winners & Key Takeaways
Biotech

The Best of AIPAT 2026: Speakers, Award Winners & Key Takeaways

SignalChem -
October 7, 2026
0
Anti-Cytokine Antibodies
Biotech

Anti-Cytokine Antibodies

SignalChem -
August 18, 2026
0
SuperNuclease for Residual DNA Removal in Biologics
Biotech

SuperNuclease for Residual DNA Removal in Biologics

SignalChem -
August 11, 2026
0
Is Your ADC Releasing Its Payload as Intended?
Biotech

Is Your ADC Releasing Its Payload as Intended?

SignalChem -
July 22, 2026
0
First Solid Tumour CAR-T Cell Approved!
Biotech

First Solid Tumour CAR-T Cell Approved!

SignalChem -
June 23, 2026
0
But what are Hexokinases?
Biotech

But what are Hexokinases?

SignalChem -
June 9, 2026
0
123...6Page 1 of 6
THE DAILY SCIENTIST

Follow SignalChem

LinkedIn
Facebook
Youtube
TikTok
Twitter

Biotech

Biotech

Oral Peptides Take Aim at Inflammation

Biotech

A New Chapter in Melanoma Research: Personalized Vaccines and the Tools Behind Discovery

Biotech

Advancing Influenza Antibody and Vaccine Development with Sino Biological

Biotech

Keeping Pace with Influenza: Recombinant Antigens for 2026–2027 Vaccine Research

Biotech

The Best of AIPAT 2026: Speakers, Award Winners & Key Takeaways

In-Vitro Diagnostics

Biotech

Oral Peptides Take Aim at Inflammation

Biotech

A New Chapter in Melanoma Research: Personalized Vaccines and the Tools Behind Discovery

Biotech

Advancing Influenza Antibody and Vaccine Development with Sino Biological

Biotech

Keeping Pace with Influenza: Recombinant Antigens for 2026–2027 Vaccine Research

Biotech

The Best of AIPAT 2026: Speakers, Award Winners & Key Takeaways

Research Articles

Biotech

Oral Peptides Take Aim at Inflammation

Biotech

A New Chapter in Melanoma Research: Personalized Vaccines and the Tools Behind Discovery

Biotech

Advancing Influenza Antibody and Vaccine Development with Sino Biological

Biotech

Keeping Pace with Influenza: Recombinant Antigens for 2026–2027 Vaccine Research

Biotech

The Best of AIPAT 2026: Speakers, Award Winners & Key Takeaways

Main Menu

  • About us
  • Resources
  • Events
  • Cookie Policy
  • Privacy Policy

Stay in touch

To be updated with all the latest news, offers and special announcements.